Sign up to save your podcasts
Or
Share Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
Host: Jennifer I. Lim, MD, FARVO
Guest: Carl Regillo, MD
What evidence do we have that blocking Ang-2 and VEGF-A is beneficial for patients? Tune in to hear Dr. Jennifer Lim and Dr. Carl Regillo examine the anatomical and biomarker evidence surrounding dual inhibition of Ang-2 and VEGF-A. Find out how bispecific targeting can benefit patients with neovascular age-related macular degeneration and diabetic macular edema.
View all episodes
By ReachMD
5
11 ratings
Host: Jennifer I. Lim, MD, FARVO
Guest: Carl Regillo, MD
What evidence do we have that blocking Ang-2 and VEGF-A is beneficial for patients? Tune in to hear Dr. Jennifer Lim and Dr. Carl Regillo examine the anatomical and biomarker evidence surrounding dual inhibition of Ang-2 and VEGF-A. Find out how bispecific targeting can benefit patients with neovascular age-related macular degeneration and diabetic macular edema.
More shows like Eye on Ocular Health
View all
Lifelong Learning
0 Listeners